| The ternary Death Domain complex of MyD88, IRAK4, and IRAK2 | |
Heteromer
O43187; Q99836; | 4-106 | 100 | |
|
| Crystal Structure of IRAK4 kinase in complex with the inhibitor CA-4948 | | homo-4-mer | 162-460 | 100.0 | 4×FJ0; |
|
| Crystal structure of Compound 19 bound to IRAK4 | | homo-4-mer | 162-458 | 100.0 | 4×QL7; 1×SO4; |
|
| CRYSTAL STRUCTURE OF INTERLEUKIN-1 RECEPTOR-ASSOCIATED KINASE 4 (IRAK4-WT) COMPLEX WITH A NICOTINAM… | | homo-4-mer | 162-458 | 100.0 | 4×R7S; 10×SO4; |
|
| Crystal Structure of IRAK4 kinase in complex with a small molecule inhibitor | | homo-4-mer | 163-458 | 100 | 4×FJ9; |
|
| Crystal structure of the unphosphorylated IRAK4 kinase domain Bound to a type I inhibitor | | homo-2-mer | 164-459 | 99.64 | 2×DL1; |
|
| IRAK4 in complex with Ponatinib | | homo-2-mer | 164-459 | 100.0 | 2×0LI; 2×SO4; 4×CO; |
|
| IRAK4 in complex with a type II inhibitor | | homo-2-mer | 164-459 | 100.0 | 2×J8A; 2×SO4; 6×CO; |
|
| Crystal structure of the unphosphorylated IRAK4 kinase domain Bound to a type I inhibitor | | homo-2-mer | 164-458 | 99.64 | 2×J87; |
|
| Crystal Structure of Asymmetric IRAK4 Dimer | | homo-2-mer | 166-458 | 99.63 | 2×STU; 3×SO4; |
|
| Sulphur Anomalous Crystal Structure of Asymmetric IRAK4 Dimer | | homo-2-mer | 166-458 | 99.63 | 2×STU; 3×SO4; |
|
| IRAK4 in complex with compound 20 | | monomer | 160-459 | 100.0 | 1×WFQ; |
|
| Crystal structure of IRAK4 in complex with compound 6 | | monomer | 162-460 | 100.0 | 1×A1AFH; |
|
| Crystal structure of IRAK4 in complex with compound 4 | | monomer | 162-460 | 100 | 1×A1AFO; |
|
| Structure of the IRAK4 kinase domain with compound 41 | | monomer | 162-459 | 100.0 | 1×SO4; 1×LSV; |
|
| Irak4-inhibitor co-structure | | monomer | 162-459 | 100.0 | 1×4S2; |
|
| Crystal structure of IRAK4 in complex with compound 14 | | monomer | 162-458 | 100.0 | 1×8CD; |
|
| Crystal structure of IRAK4 kinase domain apo form | | monomer | 162-458 | 100.0 | |
|
| Crystal structure of IRAK4 kinase domain with compound 9 | | monomer | 163-459 | 100 | 1×YJU; 1×CL; 2×GOL; |
|
| Crystal structure of human Interleukin-1 receptor associated Kinase 4 (IRAK 4, CID 100300) in compl… | | monomer | 164-460 | 100.0 | 1×JX4; |
|
| Crystal structure of IRAK4 kinase domain with inhibitor | | monomer | 163-459 | 100.0 | 1×XPY; |
|
| Irak4-inhibitor co-structure | | monomer | 163-459 | 100.0 | 1×4S3; |
|
| Irak4 kinase - compound 1 co-structure | | monomer | 163-459 | 100.0 | 1×76Q; |
|
| Irak4-inhibitor co-structure | | monomer | 163-459 | 100.0 | 1×4GD; |
|
| Irak4 kinase - compound 1 co-structure | | monomer | 163-459 | 100.0 | 1×76P; |
|
| Structure of the IRAK4 kinase domain with compound 5 | | monomer | 162-458 | 100.0 | 1×LTY; |
|
| IRAK4 IN COMPLEX WITH inhibitor | | monomer | 163-459 | 100.0 | 5×ND2; |
|
| Crystal structure of the inactive unphosphorylated IRAK4 kinase domain bound to AMP-PNP | | monomer | 164-460 | 99.65 | 1×ANP; 2×SO4; 1×MG; |
|
| Irak4-inhibitor co-structure | | monomer | 163-459 | 100.0 | 1×6YE; |
|
| Discovery of IRAK4 Inhibitor 41 | | monomer | 163-459 | 100.0 | 1×R73; |
|
| Irak4-inhibitor co-structure | | monomer | 163-459 | 100.0 | 1×42P; |
|
| Crystal structure of IRAK4 kinase domain with compound 4 | | monomer | 163-459 | 100.0 | 1×Y9T; 2×GOL; 1×SO4; |
|
| IRAK4 in complex with compound 8 | | monomer | 164-459 | 100.0 | 1×X1T; |
|
| Structure of the IRAK4 kinase domain with compound 17 | | monomer | 163-458 | 100.0 | 1×CA; 1×LRS; |
|
| IRAK4 bound to benzoxazole compound | | monomer | 164-459 | 100.0 | 1×KFD; |
|
| IRAK4 in complex with compound | | monomer | 164-459 | 100.0 | 1×VEU; 2×EDO; |
|
| IRAK4 in complex with compound 24 | | monomer | 164-459 | 100.0 | 1×VDC; |
|
| IRAK4 in complex with inhibitor | | monomer | 163-458 | 100.0 | 1×EXF; |
|
| Crystal structure of IRAK4 kinase domain complexed with staurosporine | | monomer | 163-458 | 100.0 | 1×STU; |
|
| Crystal structure of IRAK4 kinase domain with compound 8 | | monomer | 164-459 | 100.0 | 1×YK0; 1×EDO; |
|
| Crystal structure of IRAK4 in complex with compound 9 | | monomer | 164-459 | 100.0 | 1×8BV; |
|
| Irak4-inhibitor co-structure | | monomer | 164-459 | 100.0 | 1×4GF; |
|
| Crystal structure of IRAK4 in complex with compound 23 | | monomer | 164-458 | 100.0 | 1×LS7; 1×SO4; 1×GOL; |
|
| IRAK4 in complex with inhibitor | | monomer | 164-458 | 100.0 | 1×N9Z; |
|
| Crystal structure of IRAK-4 | | monomer | 164-458 | 100 | 1×SO4; 1×T12; |
|
| IRAK4 in complex with Compound 1 | | monomer | 164-458 | 100.0 | 1×6QX; |
|
| IRAK4 in complex with inhibitor | | monomer | 164-458 | 100.0 | 1×B4U; |
|
| Crystal structure of IRAK-4 | | monomer | 164-458 | 100.0 | 1×STU; |
|
| Discovery of IRAK4 Inhibitor 40 | | monomer | 165-459 | 98.96 | 1×R6I; |
|
| Discovery of IRAK4 Inhibitor 38 | | monomer | 165-459 | 98.94 | 1×O06; |
|
| IRAK4 in complex with Compound 21 | | monomer | 164-458 | 100.0 | 2×SO4; 1×6QY; |
|
| IRAK4 in complex with AZ3862 | | monomer | 164-458 | 100.0 | 2×SO4; 1×6R0; |
|
| CRYSTAL STRUCTURE OF IRAK-4 WITH A 4,6-DIAMINONICOTINAMIDE INHIBITOR (COMPOUND NUMBER 9) | | monomer | 164-458 | 100.0 | 1×9YS; |
|
| Crystal structure of IRAK4 kinase domain complexed with AMPPNP | | monomer | 164-458 | 100.0 | 1×ANP; |
|
| IRAK4 in complex with AZ3864 | | monomer | 164-458 | 100.0 | 1×6QZ; |
|
| IRAK4 IN COMPLEX WITH inhibitor | | monomer | 165-459 | 100.0 | 1×NBW; |
|
| Discovery of IRAK4 Inhibitor 16 | | monomer | 165-459 | 98.93 | 1×O0H; 1×GOL; |
|
| IRAK4 IN COMPLEX WITH inhibitor | | monomer | 164-458 | 100.0 | 1×CJN; |
|
| IRAK4 IN COMPLEX WITH inhibitor | | monomer | 164-458 | 100.0 | 1×SO4; 1×CJT; |
|
| Irak4-inhibitor co-structure | | monomer | 165-459 | 100.0 | 1×4S1; |
|
| Apo IRAK4 Kinase Domain | | monomer | 165-459 | 100.0 | |
|
| IRAK4 in complex with inhibitor | | monomer | 164-458 | 100.0 | 1×NBK; |
|
| IRAK4 IN COMPLEX WITH COMPOUND #3 | | monomer | 165-459 | 100.0 | 1×SO9; 1×BME; |
|
| Discovery of IRAK4 Inhibitor 23 | | monomer | 165-459 | 98.94 | 1×O6X; |
|
| IRAK4 IN COMPLEX WITH inhibitor | | monomer | 164-458 | 100.0 | 1×SO4; 1×CJQ; |
|
| CRYSTAL STRUCTURE OF IRAK-4 WITH A 4,6-DIAMINONICOTINAMIDE INHIBITOR (COMPOUND NUMBER 4) | | monomer | 165-459 | 100.0 | 1×9YY; |
|
| IRAK4 in complex with inhibitor | | monomer | 164-458 | 100.0 | 1×B6I; |
|
| The Crystal Structure of IRAK4 from Biortus | | monomer | 165-458 | 99.66 | 1×8CG; 3×EDO; 1×SO4; |
|
| Crystal structure of IRAK4 in complex with compound 30 | | monomer | 165-458 | 100.0 | 1×8CG; |
|
| IRAK4 in complex with inhibitor | | monomer | 165-458 | 100.0 | 1×B8I; |
|
| Discovery of IRAK4 Inhibitors BAY1834845 and BAY1830839 | | monomer | 165-458 | 98.9 | 1×R6R; |
|
| IRAK4 IN COMPLEX WITH inhibitor | | monomer | 165-458 | 100.0 | 1×CKN; |
|
| Crystal Structure of IRAK-4 | | monomer | 165-458 | 100.0 | 1×T20; |
|
| IRAK4 in complex with inhibitor | | monomer | 165-458 | 100.0 | 1×B7R; |
|
| IRAK4 IN COMPLEX WITH inhibitor | | monomer | 165-458 | 100.0 | 1×SO4; 1×K1H; |
|
| IRAK4 IN COMPLEX WITH inhibitor | | monomer | 165-458 | 100.0 | 1×NB5; |
|
| Crystal structure of IRAK4 in complex with compound 12 | | monomer | 165-458 | 100.0 | 1×8C1; |
|
| IRAK4 IN COMPLEX WITH inhibitor | | monomer | 165-458 | 100.0 | 1×K1E; |
|
| Crystal structure of IRAK4 in complex with compound 11 | | monomer | 165-458 | 100.0 | 1×8BY; |
|
| IRAK4 in complex with Compound 28 | | monomer | 165-458 | 100.0 | 1×6R1; |
|
| IRAK4 in complex with compound 23 | | monomer | 167-459 | 100.0 | 1×VE9; |
|
| Irak4-inhibitor co-structure | | monomer | 192-459 | 100.0 | |
|